Prior dengue virus serotype 3 infection modulates subsequent plasmablast responses to Zika virus infection in rhesus macaques
Immunodominant and highly conserved flavivirus envelope proteins can trigger cross-reactive IgG antibodies against related flaviviruses, which shapes subsequent protection or disease severity. This study examined how prior dengue serotype 3 (DENV-3) infection affects subsequent Zika virus (ZIKV) pla...
Saved in:
| Published in | mBio Vol. 15; no. 3; p. e0316023 |
|---|---|
| Main Authors | , , , , , , , , , , , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
United States
American Society for Microbiology
13.03.2024
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Immunodominant and highly conserved flavivirus envelope proteins can trigger cross-reactive IgG antibodies against related flaviviruses, which shapes subsequent protection or disease severity. This study examined how prior dengue serotype 3 (DENV-3) infection affects subsequent Zika virus (ZIKV) plasmablast responses in rhesus macaques (
= 4). We found that prior DENV-3 infection was not associated with diminished ZIKV-neutralizing antibodies or magnitude of plasmablast activation. Rather, characterization of 363 plasmablasts and their derivative 177 monoclonal antibody supernatants from acute ZIKV infection revealed that prior DENV-3 infection was associated with a differential isotype distribution toward IgG, lower somatic hypermutation, and lesser B cell receptor variable gene diversity as compared with repeat ZIKV challenge. We did not find long-lasting DENV-3 cross-reactive IgG after a ZIKV infection but did find persistent ZIKV-binding cross-reactive IgG after a DENV-3 infection, suggesting non-reciprocal cross-reactive immunity. Infection with ZIKV after DENV-3 boosted pre-existing DENV-3-neutralizing antibodies by two- to threefold, demonstrating immune imprinting. These findings suggest that the order of DENV and ZIKV infections has impact on the quality of early B cell immunity which has implications for optimal immunization strategies.
The Zika virus epidemic of 2015-2016 in the Americas revealed that this mosquito-transmitted virus could be congenitally transmitted during pregnancy and cause birth defects in newborns. Currently, there are no interventions to mitigate this disease and Zika virus is likely to re-emerge. Understanding how protective antibody responses are generated against Zika virus can help in the development of a safe and effective vaccine. One main challenge is that Zika virus co-circulates with related viruses like dengue, such that prior exposure to one can generate cross-reactive antibodies against the other which may enhance infection and disease from the second virus. In this study, we sought to understand how prior dengue virus infection impacts subsequent immunity to Zika virus by single-cell sequencing of antibody producing cells in a second Zika virus infection. Identifying specific qualities of Zika virus immunity that are modulated by prior dengue virus immunity will enable optimal immunization strategies. |
|---|---|
| AbstractList | Immunodominant and highly conserved flavivirus envelope proteins can trigger cross-reactive IgG antibodies against related flaviviruses, which shapes subsequent protection or disease severity. This study examined how prior dengue serotype 3 (DENV-3) infection affects subsequent Zika virus (ZIKV) plasmablast responses in rhesus macaques (
n
= 4). We found that prior DENV-3 infection was not associated with diminished ZIKV-neutralizing antibodies or magnitude of plasmablast activation. Rather, characterization of 363 plasmablasts and their derivative 177 monoclonal antibody supernatants from acute ZIKV infection revealed that prior DENV-3 infection was associated with a differential isotype distribution toward IgG, lower somatic hypermutation, and lesser B cell receptor variable gene diversity as compared with repeat ZIKV challenge. We did not find long-lasting DENV-3 cross-reactive IgG after a ZIKV infection but did find persistent ZIKV-binding cross-reactive IgG after a DENV-3 infection, suggesting non-reciprocal cross-reactive immunity. Infection with ZIKV after DENV-3 boosted pre-existing DENV-3-neutralizing antibodies by two- to threefold, demonstrating immune imprinting. These findings suggest that the order of DENV and ZIKV infections has impact on the quality of early B cell immunity which has implications for optimal immunization strategies. ABSTRACT Immunodominant and highly conserved flavivirus envelope proteins can trigger cross-reactive IgG antibodies against related flaviviruses, which shapes subsequent protection or disease severity. This study examined how prior dengue serotype 3 (DENV-3) infection affects subsequent Zika virus (ZIKV) plasmablast responses in rhesus macaques ( n = 4). We found that prior DENV-3 infection was not associated with diminished ZIKV-neutralizing antibodies or magnitude of plasmablast activation. Rather, characterization of 363 plasmablasts and their derivative 177 monoclonal antibody supernatants from acute ZIKV infection revealed that prior DENV-3 infection was associated with a differential isotype distribution toward IgG, lower somatic hypermutation, and lesser B cell receptor variable gene diversity as compared with repeat ZIKV challenge. We did not find long-lasting DENV-3 cross-reactive IgG after a ZIKV infection but did find persistent ZIKV-binding cross-reactive IgG after a DENV-3 infection, suggesting non-reciprocal cross-reactive immunity. Infection with ZIKV after DENV-3 boosted pre-existing DENV-3-neutralizing antibodies by two- to threefold, demonstrating immune imprinting. These findings suggest that the order of DENV and ZIKV infections has impact on the quality of early B cell immunity which has implications for optimal immunization strategies. IMPORTANCE The Zika virus epidemic of 2015–2016 in the Americas revealed that this mosquito-transmitted virus could be congenitally transmitted during pregnancy and cause birth defects in newborns. Currently, there are no interventions to mitigate this disease and Zika virus is likely to re-emerge. Understanding how protective antibody responses are generated against Zika virus can help in the development of a safe and effective vaccine. One main challenge is that Zika virus co-circulates with related viruses like dengue, such that prior exposure to one can generate cross-reactive antibodies against the other which may enhance infection and disease from the second virus. In this study, we sought to understand how prior dengue virus infection impacts subsequent immunity to Zika virus by single-cell sequencing of antibody producing cells in a second Zika virus infection. Identifying specific qualities of Zika virus immunity that are modulated by prior dengue virus immunity will enable optimal immunization strategies. The Zika virus epidemic of 2015–2016 in the Americas revealed that this mosquito-transmitted virus could be congenitally transmitted during pregnancy and cause birth defects in newborns. Currently, there are no interventions to mitigate this disease and Zika virus is likely to re-emerge. Understanding how protective antibody responses are generated against Zika virus can help in the development of a safe and effective vaccine. One main challenge is that Zika virus co-circulates with related viruses like dengue, such that prior exposure to one can generate cross-reactive antibodies against the other which may enhance infection and disease from the second virus. In this study, we sought to understand how prior dengue virus infection impacts subsequent immunity to Zika virus by single-cell sequencing of antibody producing cells in a second Zika virus infection. Identifying specific qualities of Zika virus immunity that are modulated by prior dengue virus immunity will enable optimal immunization strategies. ABSTRACT Immunodominant and highly conserved flavivirus envelope proteins can trigger cross-reactive IgG antibodies against related flaviviruses, which shapes subsequent protection or disease severity. This study examined how prior dengue serotype 3 (DENV-3) infection affects subsequent Zika virus (ZIKV) plasmablast responses in rhesus macaques (n = 4). We found that prior DENV-3 infection was not associated with diminished ZIKV-neutralizing antibodies or magnitude of plasmablast activation. Rather, characterization of 363 plasmablasts and their derivative 177 monoclonal antibody supernatants from acute ZIKV infection revealed that prior DENV-3 infection was associated with a differential isotype distribution toward IgG, lower somatic hypermutation, and lesser B cell receptor variable gene diversity as compared with repeat ZIKV challenge. We did not find long-lasting DENV-3 cross-reactive IgG after a ZIKV infection but did find persistent ZIKV-binding cross-reactive IgG after a DENV-3 infection, suggesting non-reciprocal cross-reactive immunity. Infection with ZIKV after DENV-3 boosted pre-existing DENV-3-neutralizing antibodies by two- to threefold, demonstrating immune imprinting. These findings suggest that the order of DENV and ZIKV infections has impact on the quality of early B cell immunity which has implications for optimal immunization strategies.IMPORTANCEThe Zika virus epidemic of 2015–2016 in the Americas revealed that this mosquito-transmitted virus could be congenitally transmitted during pregnancy and cause birth defects in newborns. Currently, there are no interventions to mitigate this disease and Zika virus is likely to re-emerge. Understanding how protective antibody responses are generated against Zika virus can help in the development of a safe and effective vaccine. One main challenge is that Zika virus co-circulates with related viruses like dengue, such that prior exposure to one can generate cross-reactive antibodies against the other which may enhance infection and disease from the second virus. In this study, we sought to understand how prior dengue virus infection impacts subsequent immunity to Zika virus by single-cell sequencing of antibody producing cells in a second Zika virus infection. Identifying specific qualities of Zika virus immunity that are modulated by prior dengue virus immunity will enable optimal immunization strategies. Immunodominant and highly conserved flavivirus envelope proteins can trigger cross-reactive IgG antibodies against related flaviviruses, which shapes subsequent protection or disease severity. This study examined how prior dengue serotype 3 (DENV-3) infection affects subsequent Zika virus (ZIKV) plasmablast responses in rhesus macaques ( = 4). We found that prior DENV-3 infection was not associated with diminished ZIKV-neutralizing antibodies or magnitude of plasmablast activation. Rather, characterization of 363 plasmablasts and their derivative 177 monoclonal antibody supernatants from acute ZIKV infection revealed that prior DENV-3 infection was associated with a differential isotype distribution toward IgG, lower somatic hypermutation, and lesser B cell receptor variable gene diversity as compared with repeat ZIKV challenge. We did not find long-lasting DENV-3 cross-reactive IgG after a ZIKV infection but did find persistent ZIKV-binding cross-reactive IgG after a DENV-3 infection, suggesting non-reciprocal cross-reactive immunity. Infection with ZIKV after DENV-3 boosted pre-existing DENV-3-neutralizing antibodies by two- to threefold, demonstrating immune imprinting. These findings suggest that the order of DENV and ZIKV infections has impact on the quality of early B cell immunity which has implications for optimal immunization strategies. The Zika virus epidemic of 2015-2016 in the Americas revealed that this mosquito-transmitted virus could be congenitally transmitted during pregnancy and cause birth defects in newborns. Currently, there are no interventions to mitigate this disease and Zika virus is likely to re-emerge. Understanding how protective antibody responses are generated against Zika virus can help in the development of a safe and effective vaccine. One main challenge is that Zika virus co-circulates with related viruses like dengue, such that prior exposure to one can generate cross-reactive antibodies against the other which may enhance infection and disease from the second virus. In this study, we sought to understand how prior dengue virus infection impacts subsequent immunity to Zika virus by single-cell sequencing of antibody producing cells in a second Zika virus infection. Identifying specific qualities of Zika virus immunity that are modulated by prior dengue virus immunity will enable optimal immunization strategies. Immunodominant and highly conserved flavivirus envelope proteins can trigger cross-reactive IgG antibodies against related flaviviruses, which shapes subsequent protection or disease severity. This study examined how prior dengue serotype 3 (DENV-3) infection affects subsequent Zika virus (ZIKV) plasmablast responses in rhesus macaques (n = 4). We found that prior DENV-3 infection was not associated with diminished ZIKV-neutralizing antibodies or magnitude of plasmablast activation. Rather, characterization of 363 plasmablasts and their derivative 177 monoclonal antibody supernatants from acute ZIKV infection revealed that prior DENV-3 infection was associated with a differential isotype distribution toward IgG, lower somatic hypermutation, and lesser B cell receptor variable gene diversity as compared with repeat ZIKV challenge. We did not find long-lasting DENV-3 cross-reactive IgG after a ZIKV infection but did find persistent ZIKV-binding cross-reactive IgG after a DENV-3 infection, suggesting non-reciprocal cross-reactive immunity. Infection with ZIKV after DENV-3 boosted pre-existing DENV-3-neutralizing antibodies by two- to threefold, demonstrating immune imprinting. These findings suggest that the order of DENV and ZIKV infections has impact on the quality of early B cell immunity which has implications for optimal immunization strategies.IMPORTANCEThe Zika virus epidemic of 2015–2016 in the Americas revealed that this mosquito-transmitted virus could be congenitally transmitted during pregnancy and cause birth defects in newborns. Currently, there are no interventions to mitigate this disease and Zika virus is likely to re-emerge. Understanding how protective antibody responses are generated against Zika virus can help in the development of a safe and effective vaccine. One main challenge is that Zika virus co-circulates with related viruses like dengue, such that prior exposure to one can generate cross-reactive antibodies against the other which may enhance infection and disease from the second virus. In this study, we sought to understand how prior dengue virus infection impacts subsequent immunity to Zika virus by single-cell sequencing of antibody producing cells in a second Zika virus infection. Identifying specific qualities of Zika virus immunity that are modulated by prior dengue virus immunity will enable optimal immunization strategies. |
| Author | O'Connor, David H Berry, Madison Permar, Sallie R Venkatayogi, Sravani Singh, Tulika Newman, Christina M Webster, Helen Eudailey, Josh A Miller, Itzayana G Dudley, Dawn M Thein, Amelia Wiehe, Kevin Kumar, Amit Breitbach, Meghan E Friedrich, Thomas C Aliota, Matthew T Mohns, Mariel S Heimsath, Holly J Mangan, Riley J |
| Author_xml | – sequence: 1 givenname: Tulika orcidid: 0000-0002-7416-7861 surname: Singh fullname: Singh, Tulika organization: Division of Infectious Disease and Vaccinology, School of Public Health, University of California, Berkeley, California, USA – sequence: 2 givenname: Itzayana G surname: Miller fullname: Miller, Itzayana G organization: Department of Pediatrics, Weill Cornell Medicine, New York, USA – sequence: 3 givenname: Sravani surname: Venkatayogi fullname: Venkatayogi, Sravani organization: Human Vaccine Institute, School of Medicine, Duke University, Durham, North Carolina, USA – sequence: 4 givenname: Helen surname: Webster fullname: Webster, Helen organization: Human Vaccine Institute, School of Medicine, Duke University, Durham, North Carolina, USA – sequence: 5 givenname: Holly J surname: Heimsath fullname: Heimsath, Holly J organization: Human Vaccine Institute, School of Medicine, Duke University, Durham, North Carolina, USA – sequence: 6 givenname: Josh A surname: Eudailey fullname: Eudailey, Josh A organization: Department of Pediatrics, Weill Cornell Medicine, New York, USA – sequence: 7 givenname: Dawn M surname: Dudley fullname: Dudley, Dawn M organization: Department of Pathology and Laboratory Medicine, University of Wisconsin-Madison, Madison, Wisconsin, USA – sequence: 8 givenname: Amit surname: Kumar fullname: Kumar, Amit organization: Human Vaccine Institute, School of Medicine, Duke University, Durham, North Carolina, USA – sequence: 9 givenname: Riley J surname: Mangan fullname: Mangan, Riley J organization: Human Vaccine Institute, School of Medicine, Duke University, Durham, North Carolina, USA – sequence: 10 givenname: Amelia surname: Thein fullname: Thein, Amelia organization: Department of Pediatrics, Weill Cornell Medicine, New York, USA – sequence: 11 givenname: Matthew T orcidid: 0000-0002-6902-9149 surname: Aliota fullname: Aliota, Matthew T organization: Department of Veterinary and Biomedical Sciences, University of Minnesota, Twin Cities, St. Paul, Minnesota, USA – sequence: 12 givenname: Christina M surname: Newman fullname: Newman, Christina M organization: Department of Pathology and Laboratory Medicine, University of Wisconsin-Madison, Madison, Wisconsin, USA – sequence: 13 givenname: Mariel S surname: Mohns fullname: Mohns, Mariel S organization: Department of Pathology and Laboratory Medicine, University of Wisconsin-Madison, Madison, Wisconsin, USA – sequence: 14 givenname: Meghan E surname: Breitbach fullname: Breitbach, Meghan E organization: Department of Pathology and Laboratory Medicine, University of Wisconsin-Madison, Madison, Wisconsin, USA – sequence: 15 givenname: Madison surname: Berry fullname: Berry, Madison organization: Human Vaccine Institute, School of Medicine, Duke University, Durham, North Carolina, USA – sequence: 16 givenname: Thomas C orcidid: 0000-0001-9831-6895 surname: Friedrich fullname: Friedrich, Thomas C organization: Department of Pathobiological Sciences, University of Wisconsin-Madison, Madison, Wisconsin, USA – sequence: 17 givenname: Kevin surname: Wiehe fullname: Wiehe, Kevin organization: Human Vaccine Institute, School of Medicine, Duke University, Durham, North Carolina, USA – sequence: 18 givenname: David H surname: O'Connor fullname: O'Connor, David H organization: Department of Pathology and Laboratory Medicine, University of Wisconsin-Madison, Madison, Wisconsin, USA – sequence: 19 givenname: Sallie R orcidid: 0000-0003-1438-4554 surname: Permar fullname: Permar, Sallie R organization: Department of Pediatrics, Weill Cornell Medicine, New York, USA |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/38349142$$D View this record in MEDLINE/PubMed |
| BookMark | eNp1ks1v1DAQxS1UREvpkSvKESGl-CtxfEKo4qNSJTjAhYs1sSdbL4kd7KRSD_zveLtLaQ_4YFszT7-Rn99zchRiQEJeMnrOGO_eTr2P51SwltZcPCEnnDW0Vg1jRw_ux-Qs5y0tSwjWCfqMHItOSM0kPyG_vyYfU-UwbFasbnxac5UxxeV2xkpUPgxoFx9DNUW3jrBgaa99xl8rhqWaR8gT9GVfqoR5jiEXwRKrH_4nHGj_ED5U6RpzqU1goRDyC_J0gDHj2eE8Jd8_fvh28bm--vLp8uL9VQ1SNkvNlWyEbvtOWXQSmxY4NKqxWmnLew0Dtwo5ciYtIu-EVr1A2jnpgHVMKHFKLvdcF2Fr5uQnSLcmgjd3hZg2BtLi7YhG6tY1TKN1jklUrBuAUWg74Wzb634orHd71rz2EzpbfEgwPoI-7gR_bTbxxjCqRSs5LYTXB0KKOxcWM_lscRwhYFyz4Zq3VCmu2yKt91KbYs4Jh_s5jJpdBMwuAuYuAoaLon-z15d_4WYb1xSKr_8Vv3r4knv033SIP-Zgv8c |
| Cites_doi | 10.1371/journal.pntd.0001568 10.3389/fimmu.2012.00078 10.1016/j.jim.2014.11.003 10.1126/science.aav6618 10.1016/j.chom.2013.05.008 10.1016/j.ebiom.2016.09.003 10.1038/s41586-021-03738-2 10.1038/265739a0 10.1038/s41590-022-01230-1 10.1126/science.1185181 10.1186/s13073-016-0276-1 10.1016/j.celrep.2021.109961 10.1371/journal.pntd.0002462 10.1073/pnas.1522136113 10.1371/journal.pntd.0006000 10.1182/blood-2008-02-078071 10.1126/science.aan6836 10.1093/infdis/jiaa120 10.1126/scitranslmed.abg9478 10.1371/journal.pntd.0007648 10.1016/j.jviromet.2009.02.014 10.1016/S0140-6736(17)31368-5 10.1038/s41467-019-10899-2 10.1126/scitranslmed.aan8184 10.3389/fimmu.2021.615102 10.3390/v11010019 10.1016/j.coviro.2020.08.006 10.1073/pnas.1607931113 10.1016/j.ebiom.2020.102733 10.1371/journal.pntd.0005168 10.1016/j.cell.2017.04.024 10.1016/j.cell.2022.10.023 10.1126/science.aaf5316 10.1038/s41467-019-08845-3 10.1093/infdis/jiy164 10.1038/s41551-020-0594-x 10.1128/JVI.03203-15 10.1371/journal.pntd.0002274 10.1016/j.jim.2010.12.008 10.1126/science.abb6143 10.1371/journal.pmed.1002726 10.1038/s41586-022-04778-y 10.1126/scitranslmed.aaw9066 10.1371/journal.pntd.0002357 10.1093/infdis/140.4.527 10.4269/ajtmh.2012.11-0770 10.1371/journal.ppat.1007766 10.1016/j.virusres.2017.06.019 10.1084/jem.20110363 10.1128/CVI.00510-16 10.1038/nrmicro1690 10.15585/mmwr.mm7103a1 10.1371/journal.pone.0201452 10.3201/eid2305.161630 10.1126/science.aaf8505 10.1038/ncomms12204 10.1128/JVI.06075-11 10.1038/ncomms14722 10.1016/j.coviro.2020.07.006 10.4049/jimmunol.1201688 10.1016/j.chom.2010.08.007 10.15585/mmwr.mm6612a4 10.1126/sciimmunol.aan6809 10.1126/science.aah6157 10.1126/scitranslmed.abm3151 10.1371/journal.ppat.1006378 10.1128/JCM.00400-21 10.1038/s41598-020-58407-7 10.1038/ncomms15674 10.1073/pnas.1921388117 10.1080/22221751.2019.1701953 10.1016/s0092-8674(02)00660-8 10.1093/infdis/jir012 10.1038/s41564-020-0714-0 10.1146/annurev-immunol-031210-101315 10.3389/fimmu.2021.777672 10.1126/scitranslmed.aay2736 10.1038/nature20564 10.1101/2023.04.09.536175 |
| ContentType | Journal Article |
| Copyright | Copyright © 2024 Singh et al. Copyright © 2024 Singh et al. 2024 Singh et al. |
| Copyright_xml | – notice: Copyright © 2024 Singh et al. – notice: Copyright © 2024 Singh et al. 2024 Singh et al. |
| DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 5PM DOA |
| DOI | 10.1128/mbio.03160-23 |
| DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef MEDLINE - Academic |
| DatabaseTitleList | CrossRef MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: DOA name: Open Access: DOAJ - Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Biology |
| EISSN | 2150-7511 |
| Editor | Ackerman, Margaret E. |
| Editor_xml | – sequence: 1 givenname: Margaret E. surname: Ackerman fullname: Ackerman, Margaret E. |
| EndPage | e0316023 |
| ExternalDocumentID | oai_doaj_org_article_496d519ecdd14e718fa10a683dc6b9bf 10_1128_mbio_03160_23 03160-23 38349142 |
| Genre | Journal Article |
| GrantInformation_xml | – fundername: NCI NIH HHS grantid: T32 CA009111 – fundername: DU | Duke Global Health Institute, Duke University (Duke Global Health Institute) grantid: Maternal Health – fundername: HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID) grantid: 1P01AI132132 – fundername: HHS | NIH | National Cancer Institute (NCI) grantid: T32 CA009111 – fundername: ; grantid: 1P01AI132132 – fundername: ; grantid: Maternal Health – fundername: ; grantid: T32 CA009111 |
| GroupedDBID | --- 0R~ 53G 5VS AAFWJ AAUOK ADBBV AENEX ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BCNDV BTFSW CGR CUY CVF DIK E3Z EBS ECM EIF FRP GROUPED_DOAJ GX1 H13 HYE HZ~ KQ8 M48 M~E NPM O5R O5S O9- OK1 P2P PGMZT RHF RHI RNS RPM RSF AFPKN AAYXX CITATION 7X8 5PM |
| ID | FETCH-LOGICAL-a445t-2745396b87ced4e56a2a575c979c2b9af2c7e2e214cee28397b3e08d4da181373 |
| IEDL.DBID | RPM |
| ISSN | 2150-7511 |
| IngestDate | Fri Oct 04 13:15:46 EDT 2024 Tue Sep 17 21:29:05 EDT 2024 Fri Aug 16 11:43:07 EDT 2024 Fri Aug 23 04:26:30 EDT 2024 Sun Aug 11 18:20:26 EDT 2024 Fri Oct 18 09:20:28 EDT 2024 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 3 |
| Keywords | B cell neutralizing antibodies plasmablast Zika virus dengue virus |
| Language | English |
| License | This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license. https://creativecommons.org/licenses/by/4.0 This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-a445t-2745396b87ced4e56a2a575c979c2b9af2c7e2e214cee28397b3e08d4da181373 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 S.R.P. serves as a consultant to Moderna, Merck, Pfizer, Dynavax, Hoopika, and GSK vaccine programs and leads sponsored research programs with Moderna, Dynavax, and Merck. |
| ORCID | 0000-0002-7416-7861 0000-0001-9831-6895 0000-0002-6902-9149 0000-0003-1438-4554 |
| OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10936420/ |
| PMID | 38349142 |
| PQID | 2926077296 |
| PQPubID | 23479 |
| PageCount | 22 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_496d519ecdd14e718fa10a683dc6b9bf pubmedcentral_primary_oai_pubmedcentral_nih_gov_10936420 proquest_miscellaneous_2926077296 crossref_primary_10_1128_mbio_03160_23 asm2_journals_10_1128_mbio_03160_23 pubmed_primary_38349142 |
| PublicationCentury | 2000 |
| PublicationDate | 2024-03-13 |
| PublicationDateYYYYMMDD | 2024-03-13 |
| PublicationDate_xml | – month: 03 year: 2024 text: 2024-03-13 day: 13 |
| PublicationDecade | 2020 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States – name: 1752 N St., N.W., Washington, DC |
| PublicationTitle | mBio |
| PublicationTitleAbbrev | mBio |
| PublicationTitleAlternate | mBio |
| PublicationYear | 2024 |
| Publisher | American Society for Microbiology |
| Publisher_xml | – name: American Society for Microbiology |
| References | LeBien, TW, Tedder, TF (B31) 2008; 112 Waickman, AT, Gromowski, GD, Rutvisuttinunt, W, Li, T, Siegfried, H, Victor, K, Kuklis, C, Gomootsukavadee, M, McCracken, MK, Gabriel, B, Mathew, A, Grinyo i Escuer, A, Fouch, ME, Liang, J, Fernandez, S, Davidson, E, Doranz, BJ, Srikiatkhachorn, A, Endy, T, Thomas, SJ, Ellison, D, Rothman, AL, Jarman, RG, Currier, JR, Friberg, H (B73) 2020; 54 Carvalho, MS, Freitas, LP, Cruz, OG, Brasil, P, Bastos, LS (B21) 2020; 10 Ikejezie, J, Shapiro, CN, Kim, J, Chiu, M, Almiron, M, Ugarte, C, Espinal, MA, Aldighieri, S (B42) 2017; 66 Aliota, MT, Dudley, DM, Newman, CM, Mohr, EL, Gellerup, DD, Breitbach, ME, Buechler, CR, Rasheed, MN, Mohns, MS, Weiler, AM, Barry, GL, Weisgrau, KL, Eudailey, JA, Rakasz, EG, Vosler, LJ, Post, J, Capuano, S, Golos, TG, Permar, SR, Osorio, JE, Friedrich, TC, O’Connor, SL, O’Connor, DH (B55) 2016; 10 Murphy, BR, Whitehead, SS (B70) 2011; 29 Priyamvada, L, Quicke, KM, Hudson, WH, Onlamoon, N, Sewatanon, J, Edupuganti, S, Pattanapanyasat, K, Chokephaibulkit, K, Mulligan, MJ, Wilson, PC, Ahmed, R, Suthar, MS, Wrammert, J (B33) 2016; 113 Han, Q, Jones, JA, Nicely, NI, Reed, RK, Shen, X, Mansouri, K, Louder, M, Trama, AM, Alam, SM, Edwards, RJ, Bonsignori, M, Tomaras, GD, Korber, B, Montefiori, DC, Mascola, JR, Seaman, MS, Haynes, BF, Saunders, KO (B79) 2019; 10 Montoya, M, Gresh, L, Mercado, JC, Williams, KL, Vargas, MJ, Gutierrez, G, Kuan, G, Gordon, A, Balmaseda, A, Harris, E, Rothman, AL (B13) 2013; 7 Godoy-Lozano, EE, Téllez-Sosa, J, Sánchez-González, G, Sámano-Sánchez, H, Aguilar-Salgado, A, Salinas-Rodríguez, A, Cortina-Ceballos, B, Vivanco-Cid, H, Hernández-Flores, K, Pfaff, JM, Kahle, KM, Doranz, BJ, Gómez-Barreto, RE, Valdovinos-Torres, H, López-Martínez, I, Rodriguez, MH, Martínez-Barnetche, J (B63) 2016; 8 Bhaumik, SK, Priyamvada, L, Kauffman, RC, Lai, L, Natrajan, MS, Cho, A, Rouphael, N, Suthar, MS, Mulligan, MJ, Wrammert, J (B40) 2018; 11 Magnani, DM, Rogers, TF, Beutler, N, Ricciardi, MJ, Bailey, VK, Gonzalez-Nieto, L, Briney, B, Sok, D, Le, K, Strubel, A (B39) 2017; 9 Robbiani, DF, Bozzacco, L, Keeffe, JR, Khouri, R, Olsen, PC, Gazumyan, A, Schaefer-Babajew, D, Avila-Rios, S, Nogueira, L, Patel, R (B57) 2017; 169 Sirohi, D, Chen, Z, Sun, L, Klose, T, Pierson, TC, Rossmann, MG, Kuhn, RJ (B6) 2016; 352 Andrade, P, Gimblet-Ochieng, C, Modirian, F, Collins, M, Cárdenas, M, Katzelnick, LC, Montoya, M, Michlmayr, D, Kuan, G, Balmaseda, A, Coloma, J, de Silva, AM, Harris, E (B26) 2019; 10 Rogers, TF, Goodwin, EC, Briney, B, Sok, D, Beutler, N, Strubel, A, Nedellec, R, Le, K, Brown, ME, Burton, DR, Walker, LM (B34) 2017; 2 Stettler, K, Beltramello, M, Espinosa, DA, Graham, V, Cassotta, A, Bianchi, S, Vanzetta, F, Minola, A, Jaconi, S, Mele, F (B9) 2016; 353 Zompi, S, Montoya, M, Pohl, MO, Balmaseda, A, Harris, E (B29) 2012; 6 Priyamvada, L, Cho, A, Onlamoon, N, Zheng, N-Y, Huang, M, Kovalenkov, Y, Chokephaibulkit, K, Angkasekwinai, N, Pattanapanyasat, K, Ahmed, R, Wilson, PC, Wrammert, J (B35) 2016; 90 Roth, NM, Reynolds, MR, Lewis, EL, Woodworth, KR, Godfred-Cato, S, Delaney, A, Akosa, A, Valencia-Prado, M, Lash, M, Elmore, A (B3) 2022; 71 Singh, T, Lopez, CA, Giuberti, C, Dennis, ML, Itell, HL, Heimsath, HJ, Webster, HS, Roark, HK, Merçon de Vargas, PR, Hall, A, Corey, RG, Swamy, GK, Dietze, R, Lazear, HM, Permar, SR (B76) 2019; 13 B75 Liao, H-X, Levesque, MC, Nagel, A, Dixon, A, Zhang, R, Walter, E, Parks, R, Whitesides, J, Marshall, DJ, Hwang, K-K, Yang, Y, Chen, X, Gao, F, Munshaw, S, Kepler, TB, Denny, T, Moody, MA, Haynes, BF (B77) 2009; 158 Xu, M, Hadinoto, V, Appanna, R, Joensson, K, Toh, YX, Balakrishnan, T, Ong, SH, Warter, L, Leo, YS, Wang, C-I, Fink, K (B37) 2012; 189 Katzelnick, LC, Gresh, L, Halloran, ME, Mercado, JC, Kuan, G, Gordon, A, Balmaseda, A, Harris, E (B14) 2017; 358 Brathwaite Dick, O, San Martín, JL, Montoya, RH, del Diego, J, Zambrano, B, Dayan, GH (B41) 2012; 87 Katzelnick, LC, Narvaez, C, Arguello, S, Lopez Mercado, B, Collado, D, Ampie, O, Elizondo, D, Miranda, T, Bustos Carillo, F, Mercado, JC, Latta, K, Schiller, A, Segovia-Chumbez, B, Ojeda, S, Sanchez, N, Plazaola, M, Coloma, J, Halloran, ME, Premkumar, L, Gordon, A, Narvaez, F, de Silva, AM, Kuan, G, Balmaseda, A, Harris, E (B20) 2020; 369 Liao, HX, Chen, X, Munshaw, S, Zhang, R, Marshall, DJ, Vandergrift, N, Whitesides, JF, Lu, X, Yu, JS, Hwang, KK (B78) 2011; 208 Rodriguez-Barraquer, I, Costa, F, Nascimento, EJM, Nery, N, Castanha, PMS, Sacramento, GA, Cruz, J, Carvalho, M, De Olivera, D, Hagan, JE, Adhikarla, H, Wunder, EA, Coêlho, DF, Azar, SR, Rossi, SL, Vasilakis, N, Weaver, SC, Ribeiro, GS, Balmaseda, A, Harris, E, Nogueira, ML, Reis, MG, Marques, ETA, Cummings, DAT, Ko, AI (B59) 2019; 363 Sevvana, M, Kuhn, RJ (B8) 2020; 45 Ricciardi, MJ, Magnani, DM, Grifoni, A, Kwon, YC, Gutman, MJ, Grubaugh, ND, Gangavarapu, K, Sharkey, M, Silveira, CGT, Bailey, VK (B30) 2017; 11 He, XS, Sasaki, S, Narvaez, CF, Zhang, C, Liu, H, Woo, JC, Kemble, GW, Dekker, CL, Davis, MM, Greenberg, HB (B74) 2011; 365 B4 Wec, AZ, Haslwanter, D, Abdiche, YN, Shehata, L, Pedreño-Lopez, N, Moyer, CL, Bornholdt, ZA, Lilov, A, Nett, JH, Jangra, RK, Brown, M, Watkins, DI, Ahlm, C, Forsell, MN, Rey, FA, Barba-Spaeth, G, Chandran, K, Walker, LM (B47) 2020; 117 Muecksch, F, Wang, Z, Cho, A, Gaebler, C, Ben Tanfous, T, DaSilva, J, Bednarski, E, Ramos, V, Zong, S, Johnson, B, Raspe, R, Schaefer-Babajew, D, Shimeliovich, I, Daga, M, Yao, KH, Schmidt, F, Millard, KG, Turroja, M, Jankovic, M, Oliveira, TY, Gazumyan, A, Caskey, M, Hatziioannou, T, Bieniasz, PD, Nussenzweig, MC (B65) 2022; 607 Pierson, TC, Diamond, MS (B5) 2020; 5 Van Rompay, KKA, Keesler, RI, Ardeshir, A, Watanabe, J, Usachenko, J, Singapuri, A, Cruzen, C, Bliss-Moreau, E, Murphy, AM, Yee, JL (B52) 2019; 11 Kuhn, RJ, Zhang, W, Rossmann, MG, Pletnev, SV, Corver, J, Lenches, E, Jones, CT, Mukhopadhyay, S, Chipman, PR, Strauss, EG, Baker, TS, Strauss, JH (B7) 2002; 108 Gordon, A, Kuan, G, Mercado, JC, Gresh, L, Avilés, W, Balmaseda, A, Harris, E (B10) 2013; 7 Andrade, DV, Harris, E (B25) 2018; 254 Breitbach, ME, Newman, CM, Dudley, DM, Stewart, LM, Aliota, MT, Koenig, MR, Shepherd, PM, Yamamoto, K, Crooks, CM, Young, G, Semler, MR, Weiler, AM, Barry, GL, Heimsath, H, Mohr, EL, Eichkoff, J, Newton, W, Peterson, E, Schultz-Darken, N, Permar, SR, Dean, H, Capuano, S, Osorio, JE, Friedrich, TC, O’Connor, DH (B43) 2019; 15 Dejnirattisai, W, Jumnainsong, A, Onsirisakul, N, Fitton, P, Vasanawathana, S, Limpitikul, W, Puttikhunt, C, Edwards, C, Duangchinda, T, Supasa, S, Chawansuntati, K, Malasit, P, Mongkolsapaya, J, Screaton, G (B38) 2010; 328 Singh, T, Hwang, K-K, Miller, AS, Jones, RL, Lopez, CA, Dulson, SJ, Giuberti, C, Gladden, MA, Miller, I, Webster, HS (B49) 2022; 185 Yewdell, WT, Smolkin, RM, Belcheva, KT, Mendoza, A, Michaels, AJ, Cols, M, Angeletti, D, Yewdell, JW, Chaudhuri, J (B66) 2021; 37 Collins, MH, McGowan, E, Jadi, R, Young, E, Lopez, CA, Baric, RS, Lazear, HM, de Silva, AM (B22) 2017; 23 Gordon, A, Gresh, L, Ojeda, S, Katzelnick, LC, Sanchez, N, Mercado, JC, Chowell, G, Lopez, B, Elizondo, D, Coloma, J, Burger-Calderon, R, Kuan, G, Balmaseda, A, Harris, E, von Seidlein, L (B60) 2019; 16 Calvert, AE, Horiuchi, K, Boroughs, KL, Ong, YT, Anderson, KM, Biggerstaff, BJ, Stone, M, Simmons, G, Busch, MP, Huang, CYH (B72) 2021; 59 Katzelnick, LC, Zambrana, JV, Elizondo, D, Collado, D, Garcia, N, Arguello, S, Mercado, JC, Miranda, T, Ampie, O, Mercado, BL (B64) 2021; 13 Montoya, M, Collins, M, Dejnirattisai, W, Katzelnick, LC, Puerta-Guardo, H, Jadi, R, Schildhauer, S, Supasa, P, Vasanawathana, S, Malasit, P, Mongkolsapaya, J, de Silva, AD, Tissera, H, Balmaseda, A, Screaton, G, de Silva, AM, Harris, E (B23) 2018; 218 Fahad, AS, Timm, MR, Madan, B, Burgomaster, KE, Dowd, KA, Normandin, E, Gutiérrez-González, MF, Pennington, JM, De Souza, MO, Henry, AR, Laboune, F, Wang, L, Ambrozak, DR, Gordon, IJ, Douek, DC, Ledgerwood, JE, Graham, BS, Castilho, LR, Pierson, TC, Mascola, JR, DeKosky, BJ (B62) 2021; 12 Fan, Q, Nelson, CS, Bialas, KM, Chiuppesi, F, Amos, J, Gurley, TC, Marshall, DJ, Eudailey, J, Heimsath, H, Himes, J, Deshpande, A, Walter, MR, Wussow, F, Diamond, DJ, Barry, PA, Moody, MA, Kaur, A, Permar, SR (B80) 2017; 24 de Oliveira, WK, de França, GVA, Carmo, EH, Duncan, BB, de Souza Kuchenbecker, R, Schmidt, MI (B2) 2017; 390 Fink, K (B32) 2012; 3 Silveira, ELV, Kasturi, SP, Kovalenkov, Y, Rasheed, AU, Yeiser, P, Jinnah, ZS, Legere, TH, Pulendran, B, Villinger, F, Wrammert, J (B45) 2015; 416 Dias, AG, Atyeo, C, Loos, C, Montoya, M, Roy, V, Bos, S, Narvekar, P, Singh, T, Katzelnick, LC, Kuan, G, Lauffenburger, DA, Balmaseda, A, Alter, G, Harris, E (B12) 2022; 14 Wrammert, J, Onlamoon, N, Akondy, RS, Perng, GC, Polsrila, K, Chandele, A, Kwissa, M, Pulendran, B, Wilson, PC, Wittawatmongkol, O, Yoksan, S, Angkasekwinai, N, Pattanapanyasat, K, Chokephaibulkit, K, Ahmed, R (B28) 2012; 86 Beltramello, M, Williams, KL, Simmons, CP, Macagno, A, Simonelli, L, Quyen, NTH, Sukupolvi-Petty, S, Navarro-Sanchez, E, Young, PR, de Silva, AM, Rey, FA, Varani, L, Whitehead, SS, Diamond, MS, Harris, E, Lanzavecchia, A, Sallusto, F (B36) 2010; 8 Sapparapu, G, Fernandez, E, Kose, N, Cao, B, Fox, JM, Bombardi, RG, Zhao, H, Nelson, CA, Bryan, AL, Barnes, T, Davidson, E, Mysorekar, IU, Fremont, DH, Doranz, BJ, Diamond, MS, Crowe, JE (B50) 2016; 540 Halstead, SB, O’Rourke, EJ (B16) 1977; 265 Parameswaran, P, Liu, Y, Roskin, KM, Jackson, KKL, Dixit, VP, Lee, JY, Artiles, KL, Zompi, S, Vargas, MJ, Simen, BB, Hanczaruk, B, McGowan, KR, Tariq, MA, Pourmand, N, Koller, D, Balmaseda, A, Boyd, SD, Harris, E, Fire, AZ (B46) 2013; 13 Nguyen, SM, Antony, KM, Dudley, DM, Kohn, S, Simmons, HA, Wolfe, B, Salamat, MS, Teixeira, LBC, Wiepz, GJ, Thoong, TH (B56) 2017; 13 Pantoja, P, Pérez-Guzmán, EX, Rodríguez, IV, White, LJ, González, O, Serrano, C, Giavedoni, L, Hodara, V, Cruz, L, Arana, T, Martínez, MI, Hassert, MA, Brien, JD, Pinto, AK, de Silva, A, Sariol, CA (B54) 2017; 8 Hatch, S, Endy, TP, Thomas, S, Mathew, A, Potts, J, Pazol e_1_3_5_27_2 e_1_3_5_25_2 e_1_3_5_23_2 e_1_3_5_21_2 e_1_3_5_44_2 e_1_3_5_65_2 e_1_3_5_46_2 e_1_3_5_67_2 e_1_3_5_48_2 e_1_3_5_69_2 e_1_3_5_29_2 e_1_3_5_80_2 e_1_3_5_40_2 e_1_3_5_61_2 e_1_3_5_42_2 e_1_3_5_63_2 e_1_3_5_7_2 e_1_3_5_9_2 e_1_3_5_3_2 e_1_3_5_39_2 e_1_3_5_16_2 e_1_3_5_37_2 e_1_3_5_14_2 e_1_3_5_12_2 e_1_3_5_35_2 e_1_3_5_10_2 e_1_3_5_33_2 e_1_3_5_54_2 e_1_3_5_77_2 e_1_3_5_56_2 e_1_3_5_79_2 e_1_3_5_58_2 e_1_3_5_18_2 e_1_3_5_71_2 e_1_3_5_50_2 e_1_3_5_73_2 e_1_3_5_52_2 e_1_3_5_75_2 e_1_3_5_31_2 e_1_3_5_28_2 e_1_3_5_26_2 e_1_3_5_24_2 e_1_3_5_22_2 e_1_3_5_43_2 e_1_3_5_66_2 e_1_3_5_45_2 e_1_3_5_68_2 e_1_3_5_47_2 e_1_3_5_49_2 e_1_3_5_81_2 e_1_3_5_2_2 e_1_3_5_60_2 e_1_3_5_62_2 e_1_3_5_41_2 e_1_3_5_64_2 e_1_3_5_8_2 e_1_3_5_20_2 e_1_3_5_4_2 e_1_3_5_6_2 e_1_3_5_17_2 e_1_3_5_38_2 e_1_3_5_15_2 e_1_3_5_36_2 e_1_3_5_13_2 e_1_3_5_34_2 e_1_3_5_11_2 e_1_3_5_32_2 e_1_3_5_55_2 e_1_3_5_76_2 e_1_3_5_57_2 e_1_3_5_78_2 e_1_3_5_59_2 e_1_3_5_19_2 e_1_3_5_70_2 e_1_3_5_51_2 e_1_3_5_72_2 e_1_3_5_53_2 e_1_3_5_74_2 e_1_3_5_30_2 |
| References_xml | – volume: 6 year: 2012 ident: B29 article-title: Dominant cross-reactive B cell response during secondary acute dengue virus infection in humans publication-title: PLoS Negl Trop Dis doi: 10.1371/journal.pntd.0001568 contributor: fullname: Harris, E – volume: 3 year: 2012 ident: B32 article-title: Origin and function of circulating plasmablasts during acute viral infections publication-title: Front Immunol doi: 10.3389/fimmu.2012.00078 contributor: fullname: Fink, K – volume: 416 start-page: 69 year: 2015 end-page: 83 ident: B45 article-title: Vaccine-induced plasmablast responses in rhesus macaques: phenotypic characterization and a source for generating antigen-specific monoclonal antibodies publication-title: J Immunol Methods doi: 10.1016/j.jim.2014.11.003 contributor: fullname: Wrammert, J – volume: 363 start-page: 607 year: 2019 end-page: 610 ident: B59 article-title: Impact of preexisting dengue immunity on Zika virus emergence in a dengue endemic region publication-title: Science doi: 10.1126/science.aav6618 contributor: fullname: Ko, AI – ident: B75 article-title: Lubow J , Levoir LM , Ralph DK , Belmont L , Contreras M , Cartwright-Acar CH , Kikawa C , Kannan S , Davidson E , Doranz BJ , Duran V , Sanchez DE , Sanz AM , Rosso F , Einav S , Matsen FA , Goo L . 2023 . Single B cell transcriptomics identifies multiple isotypes of broadly neutralizing antibodies against flaviviruses . bioRxiv . doi: 10.1101/2023.04.09.536175 – volume: 13 start-page: 691 year: 2013 end-page: 700 ident: B46 article-title: Convergent antibody signatures in human dengue publication-title: Cell Host Microbe doi: 10.1016/j.chom.2013.05.008 contributor: fullname: Fire, AZ – volume: 12 start-page: 178 year: 2016 end-page: 188 ident: B48 article-title: Plasmablasts during acute dengue infection represent a small subset of a broader virus-specific memory B cell pool publication-title: EBioMedicine doi: 10.1016/j.ebiom.2016.09.003 contributor: fullname: Fink, K – volume: 596 start-page: 109 year: 2021 end-page: 113 ident: B67 article-title: SARS-CoV-2 mRNA vaccines induce persistent human germinal centre responses publication-title: Nature doi: 10.1038/s41586-021-03738-2 contributor: fullname: Ellebedy, AH – volume: 265 start-page: 739 year: 1977 end-page: 741 ident: B16 article-title: Antibody-enhanced dengue virus infection in primate leukocytes publication-title: Nature doi: 10.1038/265739a0 contributor: fullname: O’Rourke, EJ – volume: 23 start-page: 1076 year: 2022 end-page: 1085 ident: B58 article-title: Clonal structure, stability and dynamics of human memory B cells and circulating plasmablasts publication-title: Nat Immunol doi: 10.1038/s41590-022-01230-1 contributor: fullname: Lanzavecchia, A – volume: 328 start-page: 745 year: 2010 end-page: 748 ident: B38 article-title: Enhancing cross-reactive anti-prM dominates the human antibody response in dengue infection publication-title: Science doi: 10.1126/science.1185181 contributor: fullname: Screaton, G – volume: 8 year: 2016 ident: B63 article-title: Lower IgG somatic hypermutation rates during acute dengue virus infection is compatible with a germinal center-independent B cell response publication-title: Genome Med doi: 10.1186/s13073-016-0276-1 contributor: fullname: Martínez-Barnetche, J – volume: 37 year: 2021 ident: B66 article-title: Temporal dynamics of persistent germinal centers and memory B cell differentiation following respiratory virus infection publication-title: Cell Rep doi: 10.1016/j.celrep.2021.109961 contributor: fullname: Chaudhuri, J – volume: 7 year: 2013 ident: B10 article-title: The Nicaraguan pediatric dengue cohort study: incidence of inapparent and symptomatic dengue virus infections, 2004–2010 publication-title: PLoS Negl Trop Dis doi: 10.1371/journal.pntd.0002462 contributor: fullname: Harris, E – volume: 113 start-page: 728 year: 2016 end-page: 733 ident: B11 article-title: Neutralizing antibody titers against dengue virus correlate with protection from symptomatic infection in a longitudinal cohort publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.1522136113 contributor: fullname: Harris, E – volume: 11 year: 2017 ident: B30 article-title: Ontogeny of the B- and T-cell response in a primary Zika virus infection of a dengue-naïve individual during the 2016 outbreak in Miami, FL publication-title: PLoS Negl Trop Dis doi: 10.1371/journal.pntd.0006000 contributor: fullname: Bailey, VK – volume: 112 start-page: 1570 year: 2008 end-page: 1580 ident: B31 article-title: B lymphocytes: how they develop and function publication-title: Blood doi: 10.1182/blood-2008-02-078071 contributor: fullname: Tedder, TF – volume: 358 start-page: 929 year: 2017 end-page: 932 ident: B14 article-title: Antibody-dependent enhancement of severe dengue disease in humans publication-title: Science doi: 10.1126/science.aan6836 contributor: fullname: Harris, E – volume: 222 start-page: 590 year: 2020 end-page: 600 ident: B27 article-title: Primary and secondary dengue virus infections elicit similar memory B-cell responses, but breadth to other serotypes and cross-reactivity to Zika virus is higher in secondary dengue publication-title: J Infect Dis doi: 10.1093/infdis/jiaa120 contributor: fullname: Harris, E – volume: 13 year: 2021 ident: B64 article-title: Dengue and Zika virus infections in children elicit cross-reactive protective and enhancing antibodies that persist long term publication-title: Sci Transl Med doi: 10.1126/scitranslmed.abg9478 contributor: fullname: Mercado, BL – volume: 13 year: 2019 ident: B76 article-title: Efficient transplacental IgG transfer in women infected with Zika virus during pregnancy publication-title: PLoS Negl Trop Dis doi: 10.1371/journal.pntd.0007648 contributor: fullname: Permar, SR – volume: 158 start-page: 171 year: 2009 end-page: 179 ident: B77 article-title: High-throughput isolation of immunoglobulin genes from single human B cells and expression as monoclonal antibodies publication-title: J Virol Methods doi: 10.1016/j.jviromet.2009.02.014 contributor: fullname: Haynes, BF – volume: 390 start-page: 861 year: 2017 end-page: 870 ident: B2 article-title: Infection-related microcephaly after the 2015 and 2016 Zika virus outbreaks in Brazil: a surveillance-based analysis publication-title: Lancet doi: 10.1016/S0140-6736(17)31368-5 contributor: fullname: Schmidt, MI – volume: 10 year: 2019 ident: B79 article-title: Difficult-to-neutralize global HIV-1 isolates are neutralized by antibodies targeting open envelope conformations publication-title: Nat Commun doi: 10.1038/s41467-019-10899-2 contributor: fullname: Saunders, KO – volume: 9 year: 2017 ident: B39 article-title: Neutralizing human monoclonal antibodies prevent Zika virus infection in macaques publication-title: Sci Transl Med doi: 10.1126/scitranslmed.aan8184 contributor: fullname: Strubel, A – volume: 12 start-page: 73 year: 2021 ident: B62 article-title: Functional profiling of antibody immune repertoires in convalescent Zika virus disease patients publication-title: Front Immunol doi: 10.3389/fimmu.2021.615102 contributor: fullname: DeKosky, BJ – volume: 11 year: 2018 ident: B40 article-title: Pre-existing dengue immunity drives a DENV-biased plasmablast response in ZIKV-infected patient publication-title: Viruses doi: 10.3390/v11010019 contributor: fullname: Wrammert, J – volume: 43 start-page: 59 year: 2020 end-page: 70 ident: B17 article-title: Protective and enhancing interactions among dengue viruses 1-4 and Zika virus publication-title: Curr Opin Virol doi: 10.1016/j.coviro.2020.08.006 contributor: fullname: Harris, E – volume: 113 start-page: 7852 year: 2016 end-page: 7857 ident: B33 article-title: Human antibody responses after dengue virus infection are highly cross-reactive to Zika virus publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.1607931113 contributor: fullname: Wrammert, J – volume: 54 year: 2020 ident: B73 article-title: Transcriptional and clonal characterization of B cell plasmablast diversity following primary and secondary natural DENV infection publication-title: EBioMedicine doi: 10.1016/j.ebiom.2020.102733 contributor: fullname: Friberg, H – volume: 10 year: 2016 ident: B55 article-title: Heterologous protection against Asian Zika virus challenge in rhesus macaques publication-title: PLoS Negl Trop Dis doi: 10.1371/journal.pntd.0005168 contributor: fullname: O’Connor, DH – volume: 169 start-page: 597 year: 2017 end-page: 609 ident: B57 article-title: Recurrent potent human neutralizing antibodies to Zika virus in Brazil and Mexico publication-title: Cell doi: 10.1016/j.cell.2017.04.024 contributor: fullname: Patel, R – volume: 185 start-page: 4826 year: 2022 end-page: 4840 ident: B49 article-title: A Zika virus-specific IgM elicited in pregnancy exhibits ultrapotent neutralization publication-title: Cell doi: 10.1016/j.cell.2022.10.023 contributor: fullname: Webster, HS – volume: 352 start-page: 467 year: 2016 end-page: 470 ident: B6 article-title: The 3.8Å resolution cryo-EM structure of Zika virus publication-title: Science doi: 10.1126/science.aaf5316 contributor: fullname: Kuhn, RJ – volume: 10 year: 2019 ident: B26 article-title: Impact of pre-existing dengue immunity on human antibody and memory B cell responses to Zika publication-title: Nat Commun doi: 10.1038/s41467-019-08845-3 contributor: fullname: Harris, E – volume: 218 start-page: 536 year: 2018 end-page: 545 ident: B23 article-title: Longitudinal analysis of antibody cross-neutralization following Zika virus and dengue virus infection in Asia and the Americas publication-title: J Infect Dis doi: 10.1093/infdis/jiy164 contributor: fullname: Harris, E – volume: 4 start-page: 1030 year: 2020 end-page: 1043 ident: B69 article-title: Integrated pipeline for the accelerated discovery of antiviral antibody therapeutics publication-title: Nat Biomed Eng doi: 10.1038/s41551-020-0594-x contributor: fullname: Khandhar, A – volume: 90 start-page: 5574 year: 2016 end-page: 5585 ident: B35 article-title: B cell responses during secondary dengue virus infection are dominated by highly cross-reactive, memory-derived plasmablasts publication-title: J Virol doi: 10.1128/JVI.03203-15 contributor: fullname: Wrammert, J – volume: 7 year: 2013 ident: B24 article-title: Correlation between dengue-specific neutralizing antibodies and serum avidity in primary and secondary dengue virus 3 natural infections in humans publication-title: PLoS Negl Trop Dis doi: 10.1371/journal.pntd.0002274 contributor: fullname: Harris, E – volume: 365 start-page: 67 year: 2011 end-page: 75 ident: B74 article-title: Plasmablast-derived polyclonal antibody response after influenza vaccination publication-title: J Immunol Methods doi: 10.1016/j.jim.2010.12.008 contributor: fullname: Greenberg, HB – volume: 369 start-page: 1123 year: 2020 end-page: 1128 ident: B20 article-title: Zika virus infection enhances future risk of severe dengue disease publication-title: Science doi: 10.1126/science.abb6143 contributor: fullname: Harris, E – volume: 16 year: 2019 ident: B60 article-title: Prior dengue virus infection and risk of Zika: a pediatric cohort in Nicaragua publication-title: PLoS Med doi: 10.1371/journal.pmed.1002726 contributor: fullname: von Seidlein, L – volume: 607 start-page: 128 year: 2022 end-page: 134 ident: B65 article-title: Increased memory B cell potency and breadth after a SARS-CoV-2 mRNA boost publication-title: Nature doi: 10.1038/s41586-022-04778-y contributor: fullname: Nussenzweig, MC – volume: 12 start-page: 9066 year: 2020 ident: B53 article-title: Distinct neutralizing antibody correlates of protection among related Zika virus vaccines identify a role for antibody quality publication-title: Sci Transl Med doi: 10.1126/scitranslmed.aaw9066 contributor: fullname: Fisher, BE – volume: 7 year: 2013 ident: B13 article-title: Symptomatic versus inapparent outcome in repeat dengue virus infections is influenced by the time interval between infections and study year publication-title: PLoS Negl Trop Dis doi: 10.1371/journal.pntd.0002357 contributor: fullname: Rothman, AL – volume: 140 start-page: 527 year: 1979 end-page: 533 ident: B18 article-title: In vivo enhancement of dengue virus infection in rhesus monkeys by passively transferred antibody publication-title: J Infect Dis doi: 10.1093/infdis/140.4.527 contributor: fullname: Halstead, SB – volume: 87 start-page: 584 year: 2012 end-page: 593 ident: B41 article-title: Review: the history of dengue outbreaks in the Americas publication-title: Am J Trop Med Hyg doi: 10.4269/ajtmh.2012.11-0770 contributor: fullname: Dayan, GH – volume: 15 year: 2019 ident: B43 article-title: Primary infection with dengue or Zika virus does not affect the severity of heterologous secondary infection in macaques publication-title: PLoS Pathog doi: 10.1371/journal.ppat.1007766 contributor: fullname: O’Connor, DH – volume: 254 start-page: 27 year: 2018 end-page: 33 ident: B25 article-title: Recent advances in understanding the adaptive immune response to Zika virus and the effect of previous flavivirus exposure publication-title: Virus Res doi: 10.1016/j.virusres.2017.06.019 contributor: fullname: Harris, E – volume: 208 start-page: 2237 year: 2011 end-page: 2249 ident: B78 article-title: Initial antibodies binding to HIV-1 gp41 in acutely infected subjects are polyreactive and highly mutated publication-title: J Exp Med doi: 10.1084/jem.20110363 contributor: fullname: Hwang, KK – volume: 24 year: 2017 ident: B80 article-title: Plasmablast response to primary rhesus cytomegalovirus (CMV) infection in a monkey model of congenital CMV transmission publication-title: Clin Vaccine Immunol doi: 10.1128/CVI.00510-16 contributor: fullname: Permar, SR – volume: 5 start-page: 518 year: 2007 end-page: 528 ident: B15 article-title: Prospects for a dengue virus vaccine publication-title: Nat Rev Microbiol doi: 10.1038/nrmicro1690 contributor: fullname: Murphy, BR – volume: 71 start-page: 73 year: 2022 end-page: 79 ident: B3 article-title: Zika-associated birth defects reported in pregnancies with laboratory evidence of confirmed or possible Zika virus infection — U.S. Zika pregnancy and infant registry, December 1, 2015–March 31, 2018 publication-title: MMWR Morb Mortal Wkly Rep doi: 10.15585/mmwr.mm7103a1 contributor: fullname: Elmore, A – volume: 13 year: 2018 ident: B1 article-title: Zika might not be acting alone: using an ecological study approach to investigate potential co-acting risk factors for an unusual pattern of microcephaly in Brazil publication-title: PLoS One doi: 10.1371/journal.pone.0201452 contributor: fullname: Campino, S – volume: 23 start-page: 773 year: 2017 end-page: 781 ident: B22 article-title: Lack of durable cross-neutralizing antibodies against Zika virus from dengue virus infection publication-title: Emerg Infect Dis doi: 10.3201/eid2305.161630 contributor: fullname: de Silva, AM – volume: 353 start-page: 823 year: 2016 end-page: 826 ident: B9 article-title: Specificity, cross-reactivity, and function of antibodies elicited by Zika virus infection publication-title: Science doi: 10.1126/science.aaf8505 contributor: fullname: Mele, F – volume: 7 start-page: 12204 year: 2016 ident: B44 article-title: A rhesus macaque model of Asian-lineage Zika virus infection publication-title: Nat Commun doi: 10.1038/ncomms12204 contributor: fullname: Newman, CM – volume: 86 start-page: 2911 year: 2012 end-page: 2918 ident: B28 article-title: Rapid and massive virus-specific plasmablast responses during acute dengue virus infection in humans publication-title: J Virol doi: 10.1128/JVI.06075-11 contributor: fullname: Ahmed, R – volume: 8 year: 2017 ident: B68 article-title: A human antibody against Zika virus crosslinks the E protein to prevent infection publication-title: Nat Commun doi: 10.1038/ncomms14722 contributor: fullname: Rossmann, MG – volume: 45 start-page: 51 year: 2020 end-page: 64 ident: B8 article-title: Mapping the diverse structural landscape of the flavivirus antibody repertoire publication-title: Curr Opin Virol doi: 10.1016/j.coviro.2020.07.006 contributor: fullname: Kuhn, RJ – volume: 189 start-page: 5877 year: 2012 end-page: 5885 ident: B37 article-title: Plasmablasts generated during repeated dengue infection are virus glycoprotein–specific and bind to multiple virus serotypes publication-title: J Immunol doi: 10.4049/jimmunol.1201688 contributor: fullname: Fink, K – volume: 8 start-page: 271 year: 2010 end-page: 283 ident: B36 article-title: The human immune response to dengue virus is dominated by highly cross-reactive antibodies endowed with neutralizing and enhancing activity publication-title: Cell Host Microbe doi: 10.1016/j.chom.2010.08.007 contributor: fullname: Sallusto, F – volume: 66 start-page: 329 year: 2017 end-page: 334 ident: B42 article-title: Zika virus transmission - region of the Americas, May 15, 2015-December 15, 2016 publication-title: MMWR Morb Mortal Wkly Rep doi: 10.15585/mmwr.mm6612a4 contributor: fullname: Aldighieri, S – volume: 2 year: 2017 ident: B34 article-title: Zika virus activates de novo and cross-reactive memory B cell responses in dengue-experienced donors publication-title: Sci Immunol doi: 10.1126/sciimmunol.aan6809 contributor: fullname: Walker, LM – volume: 353 start-page: 1129 year: 2016 end-page: 1132 ident: B51 article-title: Protective efficacy of multiple vaccine platforms against Zika virus challenge in rhesus monkeys publication-title: Science doi: 10.1126/science.aah6157 contributor: fullname: Nanayakkara, O – volume: 14 year: 2022 ident: B12 article-title: Antibody Fc characteristics and effector functions correlate with protection from symptomatic dengue virus type 3 infection publication-title: Sci Transl Med doi: 10.1126/scitranslmed.abm3151 contributor: fullname: Harris, E – volume: 13 year: 2017 ident: B56 article-title: Highly efficient maternal-fetal Zika virus transmission in pregnant rhesus macaques publication-title: PLoS Pathog doi: 10.1371/journal.ppat.1006378 contributor: fullname: Thoong, TH – volume: 59 year: 2021 ident: B72 article-title: The specificity of the persistent IgM neutralizing antibody response in Zika virus infections among individuals with prior dengue virus exposure publication-title: J Clin Microbiol doi: 10.1128/JCM.00400-21 contributor: fullname: Huang, CYH – volume: 10 year: 2020 ident: B21 article-title: Association of past dengue fever epidemics with the risk of Zika microcephaly at the population level in Brazil publication-title: Sci Rep doi: 10.1038/s41598-020-58407-7 contributor: fullname: Bastos, LS – ident: B4 article-title: WHO . 2022 . Zika epidemiology update report . Geneva, Switzerland – volume: 8 year: 2017 ident: B54 article-title: Zika virus pathogenesis in rhesus macaques is unaffected by pre-existing immunity to dengue virus publication-title: Nat Commun doi: 10.1038/ncomms15674 contributor: fullname: Sariol, CA – volume: 117 start-page: 6675 year: 2020 end-page: 6685 ident: B47 article-title: Longitudinal dynamics of the human B cell response to the yellow fever 17D vaccine publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.1921388117 contributor: fullname: Walker, LM – volume: 9 start-page: 111 year: 2020 end-page: 123 ident: B61 article-title: Longitudinal analysis of the antibody repertoire of a Zika virus-infected patient revealed dynamic changes in antibody response publication-title: Emerg Microbes Infect doi: 10.1080/22221751.2019.1701953 contributor: fullname: Liang, R – volume: 108 start-page: 717 year: 2002 end-page: 725 ident: B7 article-title: Structure of dengue virus: implications for flavivirus organization, maturation, and fusion publication-title: Cell doi: 10.1016/s0092-8674(02)00660-8 contributor: fullname: Strauss, JH – volume: 203 start-page: 1282 year: 2011 end-page: 1291 ident: B19 article-title: Intracellular cytokine production by dengue virus-specific T cells correlates with subclinical secondary infection publication-title: J Infect Dis doi: 10.1093/infdis/jir012 contributor: fullname: Rothman, AL – volume: 5 start-page: 796 year: 2020 end-page: 812 ident: B5 article-title: The continued threat of emerging flaviviruses publication-title: Nat Microbiol doi: 10.1038/s41564-020-0714-0 contributor: fullname: Diamond, MS – volume: 29 start-page: 587 year: 2011 end-page: 619 ident: B70 article-title: Immune response to dengue virus and prospects for a vaccine publication-title: Annu Rev Immunol doi: 10.1146/annurev-immunol-031210-101315 contributor: fullname: Whitehead, SS – volume: 12 year: 2021 ident: B71 article-title: Monomeric IgA antagonizes IgG-mediated enhancement of DENV infection publication-title: Front Immunol doi: 10.3389/fimmu.2021.777672 contributor: fullname: Waickman, AT – volume: 11 start-page: 1 year: 2019 end-page: 12 ident: B52 article-title: DNA vaccination before conception protects Zika virus–exposed pregnant macaques against prolonged viremia and improves fetal outcomes publication-title: Sci Transl Med doi: 10.1126/scitranslmed.aay2736 contributor: fullname: Yee, JL – volume: 540 start-page: 443 year: 2016 end-page: 447 ident: B50 article-title: Neutralizing human antibodies prevent Zika virus replication and fetal disease in mice publication-title: Nature doi: 10.1038/nature20564 contributor: fullname: Crowe, JE – ident: e_1_3_5_26_2 doi: 10.1016/j.virusres.2017.06.019 – ident: e_1_3_5_13_2 doi: 10.1126/scitranslmed.abm3151 – ident: e_1_3_5_57_2 doi: 10.1371/journal.ppat.1006378 – ident: e_1_3_5_73_2 doi: 10.1128/JCM.00400-21 – ident: e_1_3_5_44_2 doi: 10.1371/journal.ppat.1007766 – ident: e_1_3_5_40_2 doi: 10.1126/scitranslmed.aan8184 – ident: e_1_3_5_10_2 doi: 10.1126/science.aaf8505 – ident: e_1_3_5_14_2 doi: 10.1371/journal.pntd.0002357 – ident: e_1_3_5_72_2 doi: 10.3389/fimmu.2021.777672 – ident: e_1_3_5_47_2 doi: 10.1016/j.chom.2013.05.008 – ident: e_1_3_5_38_2 doi: 10.4049/jimmunol.1201688 – ident: e_1_3_5_3_2 doi: 10.1016/S0140-6736(17)31368-5 – ident: e_1_3_5_79_2 doi: 10.1084/jem.20110363 – ident: e_1_3_5_8_2 doi: 10.1016/s0092-8674(02)00660-8 – ident: e_1_3_5_34_2 doi: 10.1073/pnas.1607931113 – ident: e_1_3_5_27_2 doi: 10.1038/s41467-019-08845-3 – ident: e_1_3_5_51_2 doi: 10.1038/nature20564 – ident: e_1_3_5_12_2 doi: 10.1073/pnas.1522136113 – ident: e_1_3_5_46_2 doi: 10.1016/j.jim.2014.11.003 – ident: e_1_3_5_50_2 doi: 10.1016/j.cell.2022.10.023 – ident: e_1_3_5_20_2 doi: 10.1093/infdis/jir012 – ident: e_1_3_5_71_2 doi: 10.1146/annurev-immunol-031210-101315 – ident: e_1_3_5_81_2 doi: 10.1128/CVI.00510-16 – ident: e_1_3_5_35_2 doi: 10.1126/sciimmunol.aan6809 – ident: e_1_3_5_61_2 doi: 10.1371/journal.pmed.1002726 – ident: e_1_3_5_11_2 doi: 10.1371/journal.pntd.0002462 – ident: e_1_3_5_78_2 doi: 10.1016/j.jviromet.2009.02.014 – ident: e_1_3_5_21_2 doi: 10.1126/science.abb6143 – ident: e_1_3_5_43_2 doi: 10.15585/mmwr.mm6612a4 – ident: e_1_3_5_60_2 doi: 10.1126/science.aav6618 – ident: e_1_3_5_64_2 doi: 10.1186/s13073-016-0276-1 – ident: e_1_3_5_17_2 doi: 10.1038/265739a0 – ident: e_1_3_5_56_2 doi: 10.1371/journal.pntd.0005168 – ident: e_1_3_5_29_2 doi: 10.1128/JVI.06075-11 – ident: e_1_3_5_36_2 doi: 10.1128/JVI.03203-15 – ident: e_1_3_5_77_2 doi: 10.1371/journal.pntd.0007648 – ident: e_1_3_5_39_2 doi: 10.1126/science.1185181 – ident: e_1_3_5_68_2 doi: 10.1038/s41586-021-03738-2 – ident: e_1_3_5_55_2 doi: 10.1038/ncomms15674 – ident: e_1_3_5_41_2 doi: 10.3390/v11010019 – ident: e_1_3_5_2_2 doi: 10.1371/journal.pone.0201452 – ident: e_1_3_5_23_2 doi: 10.3201/eid2305.161630 – ident: e_1_3_5_45_2 doi: 10.1038/ncomms12204 – ident: e_1_3_5_42_2 doi: 10.4269/ajtmh.2012.11-0770 – ident: e_1_3_5_59_2 doi: 10.1038/s41590-022-01230-1 – ident: e_1_3_5_75_2 doi: 10.1016/j.jim.2010.12.008 – ident: e_1_3_5_16_2 doi: 10.1038/nrmicro1690 – ident: e_1_3_5_28_2 doi: 10.1093/infdis/jiaa120 – ident: e_1_3_5_80_2 doi: 10.1038/s41467-019-10899-2 – ident: e_1_3_5_4_2 doi: 10.15585/mmwr.mm7103a1 – ident: e_1_3_5_66_2 doi: 10.1038/s41586-022-04778-y – ident: e_1_3_5_7_2 doi: 10.1126/science.aaf5316 – ident: e_1_3_5_6_2 doi: 10.1038/s41564-020-0714-0 – ident: e_1_3_5_52_2 doi: 10.1126/science.aah6157 – ident: e_1_3_5_19_2 doi: 10.1093/infdis/140.4.527 – ident: e_1_3_5_30_2 doi: 10.1371/journal.pntd.0001568 – ident: e_1_3_5_67_2 doi: 10.1016/j.celrep.2021.109961 – ident: e_1_3_5_58_2 doi: 10.1016/j.cell.2017.04.024 – ident: e_1_3_5_15_2 doi: 10.1126/science.aan6836 – ident: e_1_3_5_37_2 doi: 10.1016/j.chom.2010.08.007 – ident: e_1_3_5_74_2 doi: 10.1016/j.ebiom.2020.102733 – ident: e_1_3_5_18_2 doi: 10.1016/j.coviro.2020.08.006 – ident: e_1_3_5_24_2 doi: 10.1093/infdis/jiy164 – ident: e_1_3_5_31_2 doi: 10.1371/journal.pntd.0006000 – ident: e_1_3_5_22_2 doi: 10.1038/s41598-020-58407-7 – ident: e_1_3_5_53_2 doi: 10.1126/scitranslmed.aay2736 – ident: e_1_3_5_33_2 doi: 10.3389/fimmu.2012.00078 – ident: e_1_3_5_49_2 doi: 10.1016/j.ebiom.2016.09.003 – ident: e_1_3_5_62_2 doi: 10.1080/22221751.2019.1701953 – ident: e_1_3_5_32_2 doi: 10.1182/blood-2008-02-078071 – ident: e_1_3_5_48_2 doi: 10.1073/pnas.1921388117 – ident: e_1_3_5_9_2 doi: 10.1016/j.coviro.2020.07.006 – ident: e_1_3_5_25_2 doi: 10.1371/journal.pntd.0002274 – ident: e_1_3_5_70_2 doi: 10.1038/s41551-020-0594-x – ident: e_1_3_5_54_2 doi: 10.1126/scitranslmed.aaw9066 – ident: e_1_3_5_69_2 doi: 10.1038/ncomms14722 – ident: e_1_3_5_65_2 doi: 10.1126/scitranslmed.abg9478 – ident: e_1_3_5_76_2 doi: 10.1101/2023.04.09.536175 – ident: e_1_3_5_63_2 doi: 10.3389/fimmu.2021.615102 |
| SSID | ssj0000331830 |
| Score | 2.4229138 |
| Snippet | Immunodominant and highly conserved flavivirus envelope proteins can trigger cross-reactive IgG antibodies against related flaviviruses, which shapes... ABSTRACT Immunodominant and highly conserved flavivirus envelope proteins can trigger cross-reactive IgG antibodies against related flaviviruses, which shapes... |
| SourceID | doaj pubmedcentral proquest crossref asm2 pubmed |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database |
| StartPage | e0316023 |
| SubjectTerms | Animals Antibodies, Neutralizing Antibodies, Viral B cell Cross Reactions Dengue Dengue Virus Flavivirus Immunoglobulin G Immunology Macaca mulatta neutralizing antibodies plasmablast Research Article Serogroup Zika Virus Zika Virus Infection |
| SummonAdditionalLinks | – databaseName: American Society for Microbiology Open Access dbid: AAUOK link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Lb9QwELbKVkhcEG-2QGUE4pYSP-LYx21FVYF4HFip4mLZsU0jlKRKspU48N8Z57GwFZW45GA7Tuxv7PnGHo8Rek2s8DxkNlHCyIQ7xRLlUp7YQKRXIYCKiWeHP34SZ2v-_jw730N0Pgsz9WB3ZLpq2Mjfjmwq31a2bI5ACkWaUHYL7YP8yHSB9ler9ecP25WVlEU5TeeAmtffg7kX6qY7emgI1_8vjnndVfIv3XN6D92dSCNejSjfR3u-foBuj9dI_nyIfn1py6bFMIN833h8VbabDoNkNXF5FTM8-1vVuGpcvK3LQzbMF4MTdY8vgT9XxsKzx-3oMQsF-gZ_K3-YqbY_VZQ1bi98B2mVKUxsxiO0Pn339eQsma5VSAznWZ-AHZoxJazMC--4z4ShBkhboXJVUKtMoEXuqaeEgwIF9qFyy3wqHXcG6ADL2WO0qJvaP0VYEpHnQalQEMvzNBggj44C9I6YLHC6RK9iX-sZVT2YHFTqiIgeENGULdGbGQp9OcbYuKngcQRqWyiGxh4SQFD0NNI0V8IBLfWFc4R7UL3BkNQIyVwhrLJhiV7OMGsYSnF_xNS-2XSaKjDuorUhlujJCPv2U2DIc0Vii-SOQOz8y25OXV4M4bpjwC6w8tKD_-qMZ-gOBd4U3dwIe44WfbvxL4D39PZwEvTfDTQDPw priority: 102 providerName: American Society for Microbiology – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1La9wwEBZhoZBL6bvbpkGlpTc31sOydExCQigk5NBA6EVIltSYYjvY3kIP_e8dyd5kt7T00osPspAlfaOZb-zxDELviRWeh8JmShiZcadYplzOMxuI9CoEMDHx3-HzC3F2xT9dF9cbpb5iTNiUHnjauAOuhAOW4SvnCPegSYMhuRGSuUpYZUPSvqTYcKaSDmZRVvN1Uk0qDxpbdx9BgkWexdJECzM0dMsWpZT9f-KZv4dLbtif00fo4Uwc8eE04cdox7dP0IOplOSPp-jnZV93PQYt8nXl8fe6Xw0YpKuLr1gxw-uYqxY3nYsVuzzcBp2RAqlHfAscujEWriPup6hZ6DB2-Ev9zcyj3Q9Rt7i_8QO0NaYycRnP0NXpyefjs2wurZAZzosxA1-0YEpYWVbecV8IQw0Qt0qVqqJWmUCr0lNPCQcjCgxElZb5XDruDFACVrLnaNF2rX-JsCSiLINSoSKWl3kwQCAdBfgdMUXgdInexb3W89kYdHI7qNQREZ0Q0ZQt0Yc1FPp2yrPxt45HEai7TjE9dmoAodGz0Oh_Cc0SvV3DrOE4xW8kpvXdatBUgYMXPQ6xRC8m2O8eBc48VySuSG4JxNZctu-09U1K2R2TdoGnl7_6H7N_jXYpUKsYCUfYHlqM_cq_AWo02v10Cn4BQXIQUQ priority: 102 providerName: Directory of Open Access Journals – databaseName: Scholars Portal Journals: Open Access dbid: M48 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Jb9UwELagCIlLVfZXFhmBuKXESxz7gBAgqgqpiANPqrhYdmy3UUnSJnkVPfS_M87S8qoiccnBcezY39jzTTKeQegNscLzkNlECSMT7hRLlEt5YgORXoUAKiaeHd7_JvaW_OtBdnAVUmiawO5G0y7mk1q2v3Z-n55_gAX_fjwAI99Vtmx2QDhFmlB2G92hnPEo7PsT0x82ZRaFN52jbF5_CjZk01V0TTkNMfxvIp7X_Sf_Uki7W2hzYpL44wj9fXTL1w_Q3TG35PlDdPG9LZsWw7ZyuPL4rGxXHQZxa-I3V8zw7IRV46pxMYWXh9uwiQye1T0-AVJdGQvXHrejGy1U6Bv8szw2U2tXTZQ1bo98B2WVKUwcxiO03P3y4_NeMuVaSAznWZ-AcZoxJazMC--4z4ShBphcoXJVUKtMoEXuqaeEg1YFSqJyy3wqHXcGOALL2WO0UTe1f4qwJCLPg1KhIJbnaTDAKB0FeXDEZIHTBXod51rPWOvBDqFSR0T0gIimbIHezlDokzHwxr8qfopAXVaK8bKHgqY91NPy01wJB1zVF84R7kEfB0NSIyRzhbDKhgV6NcOsYX3Fnyam9s2q01SBxRdNELFAT0bYL7sC654rEkck1wRi7V3W79Tl0RDDO0bxAtMv3f6Pjp-hexSoVPR8I-w52ujblX8BVKi3Lwch_wM_zwu- priority: 102 providerName: Scholars Portal |
| Title | Prior dengue virus serotype 3 infection modulates subsequent plasmablast responses to Zika virus infection in rhesus macaques |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/38349142 https://journals.asm.org/doi/10.1128/mbio.03160-23 https://search.proquest.com/docview/2926077296 https://pubmed.ncbi.nlm.nih.gov/PMC10936420 https://doaj.org/article/496d519ecdd14e718fa10a683dc6b9bf |
| Volume | 15 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lj9MwELZ2i5C4IN6ER2UE4pY2fsSJj2XFsgIV9kCliktkx_ZuBEmqJEXiwH9n7DbLFsGFiw-O4ziZz55vnPEMQq-IFpa7VMdSqDzmRrJYmoTH2pHcSudAxfizw8uP4mzF36_T9RES41mY4LRf6mrWfKtnTXUZfCs3dTkf_cTm58sTHwIJeHMyP0bHGWPXbPSw_jKP02QMqEnzea2rdgboFUlMfeIcsMq4JD47-0T1NT1QSSFy_9_o5p9ek9fU0OkddHvPH_FiN8676Mg299DNXUbJH_fRz_OuajsMi8nF1uLvVbftMYCs9TutmOHR9arBdWt84i4Ll2HpCP7UA94Ala6VhnLA3c55FhoMLf5SfVX73n53UTW4u7Q91NWqVP41HqDV6dvPJ2fxPsNCrDhPhxhM0pRJofOstIbbVCiqgL-VMpMl1VI5WmaWWko46FIgIjLTzCa54UYBM2AZe4gmTdvYxwjnRGSZk9KVRPMscQp4pKGAAkNU6jiN0Ev_rYv9FOmLYH3QvPDCKYJwCsoi9HoURbHZhdv4V8M3XlBXjXyU7FDRdhfFHisFl8IAQ7WlMYRb0MJOkUSJnJlSaKldhF6MYi5gVvlfJaqx7bYvqAQ7zxseIkKPdmK_etSIngjlB4A4GMvhFQByiNw9AvfJ_9_6FN2iwKu8Gxxhz9Bk6Lb2OfCiQU_RjcVi9enDNOwrQPluTaBc8nwaJsgvOesUig |
| link.rule.ids | 230,315,733,786,790,870,891,2115,24346,27955,27956,53180,53193,53206,53825,53827 |
| linkProvider | National Library of Medicine |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Lb9QwELZKK0QviDfL0wjELW38iBMfF0S10AcculLFxbJjm4aSpEqySBz474zzWNgKJC45OI4de2Y839jjGYReESMc94mJpNBZxK1kkbQxj4wnmZPeg4oJd4ePT8RiyT-cJWdbSEx3Yb6GvLzf2j3dlv05fhDssBE95iPM9ktT1HvAiSKOKLuGdkJiA-Dsnfl8-fFwvbsSs8Cr8RRU8-p3sP5CB3RDF_Uh-_-GM6-6S_6hfw5uoZsjcMTzgdK30Zar7qDrQyrJH3fRz09NUTcYVpEvK4e_F82qxcBdddhixQxPPlcVLmsbMnY5eA1rRu9I3eFLwNClNvDscDN4zUKFrsafiws9tva7iaLCzblroazUuQ7DuIeWB-9O3y6iMbVCpDlPughs0YRJYbI0d5a7RGiqAbjlMpU5NVJ7mqeOOko4KFFAIDI1zMWZ5VYDJGApu4-2q7pyDxHOiEhTL6XPieFp7DUASEuB_JboxHM6Qy_DXKtRNlrVmx00U4EiqqeIomyGXk-kUJdDnI1_VXwTCLWuFMJj9wXALWqUNsWlsABNXW4t4Q7Ur9ck1iJjNhdGGj9DLyYyKxCncEaiK1evWkUlGHjB4hAz9GAg-7orMOa5JGFE2QZDbPzL5puqOO9DdoegXWDpxY_-azKeoxuL0-MjdfT-5PAx2qWAo4LbG2FP0HbXrNxTwEGdeTYy_S8q3AeZ |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Lb9QwELZKKxAXVN4LBYxA3FLiR5z4uAVWhULpgZUqLpYd2zRCSVZJFokD_73jPBa2AolLDrbjxP7Gnm_s8Rihl8QIx31iIil0FnErWSRtzCPjSeak96BiwtnhT6fieMk_nCfnO0hMZ2HGHmwPdVv2G_lhZK-sH-8jzF6XpqgPQRJFHFF2De0FGQL53pvPl59PNqsrMQuyGk9BNa--B_Mv1E-3dFEfsv9vPPOqu-Qf-mexj26NxBHPB6Rvox1X3UHXh6skf95Fv86aom4wzCLf1g7_KJp1i0G66rDEihmefK4qXNY23NjlIBvmjN6RusMr4NClNvDscDN4zUKBrsZfi-96rO13FUWFmwvXQlqpcx2acQ8tF---vDmOxqsVIs150kVgiyZMCpOlubPcJUJTDcQtl6nMqZHa0zx11FHCQYkCA5GpYS7OLLcaKAFL2X20W9WVe4hwRkSaeil9TgxPY6-BQFoK8FuiE8_pDL0Ifa0mZFVvdtBMBURUj4iibIZeTVCo1RBn418FjwJQm0IhPHafAMKixtGmuBQWqKnLrSXcgfr1msRaZMzmwkjjZ-j5BLOC4RT2SHTl6nWrqAQDL1gcYoYeDLBvPgXGPJcktCjbEoitf9nOqYqLPmR3CNoFll786L864xm6cfZ2oT6-Pz15jG5SoFHB642wA7TbNWv3BGhQZ56OMn8JIegHPg |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Prior+dengue+virus+serotype+3+infection+modulates+subsequent+plasmablast+responses+to+Zika+virus+infection+in+rhesus+macaques&rft.jtitle=mBio&rft.au=Singh%2C+Tulika&rft.au=Miller%2C+Itzayana+G&rft.au=Venkatayogi%2C+Sravani&rft.au=Webster%2C+Helen&rft.date=2024-03-13&rft.eissn=2150-7511&rft.volume=15&rft.issue=3&rft.spage=e0316023&rft.epage=e0316023&rft_id=info:doi/10.1128%2Fmbio.03160-23&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2150-7511&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2150-7511&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2150-7511&client=summon |